Alnylam Pharmaceuticals, Inc.

VOYA INVESTMENT MANAGEMENT LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

198,613

Value ($000)

78,978

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	78,978	0.1%	198,613	12/31/2025
2025 Q3	10/9/2025	170,250	0.2%	373,356	9/30/2025
2025 Q2	8/14/2025	68,820	0.1%	211,045	6/30/2025
2025 Q1	5/15/2025	24,611	0.0%	91,144	3/31/2025
2024 Q4	5/2/2025	22,375	0.0%	95,086	12/31/2024
2024 Q3	2/7/2025	29,898	0.0%	108,709	9/30/2024
2024 Q2	2/7/2025	27,759	0.0%	114,234	6/30/2024
2024 Q1	2/7/2025	10,536	0.0%	70,497	3/31/2024
2023 Q4	2/7/2025	16,102	0.0%	84,123	12/31/2023
2023 Q3	2/7/2025	27,292	0.0%	154,104	9/30/2023
2023 Q2	2/7/2025	28,037	0.0%	147,610	6/30/2023
2023 Q1	2/7/2025	34,583	0.0%	172,640	3/31/2023
2022 Q4	2/7/2025	44,013	0.1%	185,199	12/31/2022
2022 Q3	2/7/2025	17,153	0.0%	85,694	9/30/2022
2022 Q2	8/15/2022	7,468	0.0%	51,201	6/30/2022
2022 Q1	5/16/2022	9,517	0.0%	58,283	3/31/2022
2021 Q4	2/14/2022	9,959	0.0%	58,727	12/31/2021
2021 Q3	11/15/2021	7,076	0.0%	37,479	9/30/2021
2021 Q2	8/16/2021	6,413	0.0%	37,829	6/30/2021
2021 Q1	5/17/2021	5,398	0.0%	38,232	3/31/2021
2020 Q4	2/16/2021	5,293	0.0%	40,725	12/31/2020
2020 Q3	11/16/2020	6,235	0.0%	42,820	9/30/2020
2020 Q2	8/14/2020	6,532	0.0%	44,102	6/30/2020
2020 Q1	5/15/2020	3,842	0.0%	35,295	3/31/2020
2019 Q4	2/14/2020	4,143	0.0%	35,977	12/31/2019
2014 Q1	5/15/2014	2,191	0.0%	32,634	3/31/2014
2013 Q4	2/12/2014	2,099	0.0%	32,634	12/31/2013